DiscoverBase by Base
Base by Base

Base by Base

Author: Gustavo Barra

Subscribed: 9Played: 805
Share

Description

Base by Base explores advances in genetics and genomics, with a focus on gene-disease associations, variant interpretation, protein structure, and insights from exome and genome sequencing. Each episode breaks down key studies and their clinical relevance—one base at a time.

Powered by AI, Base by Base offers a new way to learn on the go. Special thanks to authors who publish under CC BY 4.0, making open-access science faster to share and easier to explore.
478 Episodes
Reverse
Ihejirika S et al., Human Genetics and Genomics Advances - This study asks why the same fish oil supplement can shift blood fatty acids differently from person to person. Using a two-stage strategy in UK Biobank participants of European ancestry, the authors first searched the genome for variants linked to the spread, or variance, of 14 plasma polyunsaturated and monounsaturated fatty acid traits, and then tested those variants for interaction with regular fish oil use. Key terms: gene-environment interaction, variance QTL, fish oil supplements, polyunsaturated fatty acids, UK Biobank. Study Highlights:The genome-wide variance scan, in up to 200,736 participants, found 172 variance QTL-trait pairs across the 14 traits, mapping to 46 non-overlapping loci; 16 of them had no detectable effect on the trait mean. In the interaction stage, with 200,060 participants of whom about 31.8% regularly took fish oil, six significant gene-fish oil interactions emerged, in DHA, DHA%, Omega-3, Omega-3%, LA and the Omega-6/Omega-3 ratio. They mapped to the FADS1/2 region, to ZPR1 near the APOA5 apolipoprotein cluster, and to SUGP1/TM6SF2, the last two not detected in the authors' earlier genome-wide interaction scan. Significant interactions were enriched 8.12-fold among variance QTLs compared with ordinary mean-effect loci, with a wide 95% bootstrap confidence interval of 2.26 to 27.07. Conclusion:Screening for variants that change trait variance helped the authors find two additional loci where genotype modifies the association between fish oil use and circulating fatty acids, such as a larger DHA increase with fish oil in carriers of the ZPR1 rs964184 G allele. The findings are associations in participants of European ancestry, fish oil use was a self-reported yes or no without dose or composition, and the mechanisms remain hypotheses that need replication and functional study. Article title:A variance QTL approach to uncover gene-fish oil supplement interaction loci for 14 circulating unsaturated fatty acid traits First author:Ihejirika S Journal:Human Genetics and Genomics Advances DOI:10.1016/j.xhgg.2026.100675 Reference:Ihejirika S.A., Stephen E., Ye K. A variance QTL approach to uncover gene-fish oil supplement interaction loci for 14 circulating unsaturated fatty acid traits. Human Genetics and Genomics Advances, 100675. (2026). https://doi.org/10.1016/j.xhgg.2026.100675 License:This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/ Support:Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase More at basebybase.com On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics. Episode link: https://basebybase.com/episodes/fish-oil-gene-interaction-variance-qtl-fatty-acids QC:This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded. QC Summary:- sentences checked: 166- supported by the article: 164- flagged and reviewed by a human: 2- metadata checks passed: 3 of 4 QC result: Warn. Chapters (00:00:03) - A ZPR1 variant and fish oil's effect on DHA(00:00:40) - The challenge of detecting gene-environment interactions(00:01:14) - About Base by Base and fact-checking(00:01:35) - Crediting the researchers and paper(00:02:10) - The variance-based intuition for finding interactions(00:02:44) - Background on unsaturated fatty acids(00:03:21) - Fish oil, essential fatty acids, and FADS genes(00:04:30) - Gene-environment interactions are hard to detect(00:05:05) - Prior direct genome-wide interaction study results(00:05:49) - A two-stage strategy: variance scan then interaction test(00:06:27) - UK Biobank study data and methods(00:07:35) - Measuring fatty acids and fish oil use(00:08:06) - Statistical methods: Levene's test and thresholds(00:08:46) - Variant scan results across 46 genomic regions(00:09:25) - Pleiotropic loci: TRIB1 and GCKR(00:10:05) - Tissue and pathway enrichment findings(00:10:36) - Comparing variance variants to mean-effect variants(00:11:17) - The 16 intriguing variance-only variants and KSRT2(00:11:49) - Fish oil use reveals hidden KSRT2 effect(00:12:24) - Stage 2 results: six significant interactions found(00:13:17) - ZPR1 and DHA response by genotype(00:13:43) - SUGP1/TM6SF2 region and linoleic acid interaction(00:14:27) - Robustness checks against confounders(00:14:52) - Testing whether the variance filter actually helped(00:15:31) - Enrichment confirmed with looser p-value cutoff(00:16:14) - Implications: a strategy and public resource(00:16:44) - Interpreting findings cautiously(00:17:21) - Study limitations(00:17:58) - Summary and takeaways(00:18:43) - Closing thoughts on personalized nutrition(00:18:56) - Outro and credits
Argilli E et al., The American Journal of Human Genetics - This research letter describes nine unrelated individuals with rare heterozygous missense variants in ABI2, a gene for a cytoskeletal adaptor protein that works in Rac-WAVE signaling and actin remodeling. Seven of them carry the same de novo change, p.Tyr491Cys, in the SH3 domain, and their brain MRIs show a consistent pattern led by a thin corpus callosum, the bundle of fibers that links the two brain hemispheres. Key terms: ABI2, corpus callosum hypoplasia, de novo variant, neurodevelopmental disorder, Rac-WAVE signaling. Study Highlights:Individuals were found through exome or genome sequencing and international data sharing via GeneMatcher, with clinical data from medical records and clinician questionnaires and centrally reviewed brain MRIs. Seven individuals carried the recurrent p.Tyr491Cys variant and two carried distinct de novo variants, p.Val204Met and p.Val463Ala; all variants were absent from gnomAD v4.1. All nine had moderate-to-severe developmental delay and/or intellectual disability, epilepsy occurred in six, and macrocephaly ranging from +2.5 to +4.2 SD was seen in seven of eight individuals. Every individual with p.Tyr491Cys showed marked corpus callosum hypoplasia and periventricular T2-FLAIR hyperintensities, while the two individuals with nonrecurrent variants lacked corpus callosum abnormalities. Conclusion:The authors establish ABI2 as a neurodevelopmental disorder-associated gene and identify the recurrent p.Tyr491Cys variant as defining a distinctive syndrome with corpus callosum hypoplasia and white matter abnormalities, consistent with other Rac-WAVE pathway disorders and with Abi2-deficient mice. The cohort is small, nine individuals, and the mechanism is inferred from structural modeling and prediction tools; the authors state that future functional studies will be needed to explain how the variants cause disease. Article title:Recurrent de novo ABI2 p.Tyr491Cys variants define a neurodevelopmental syndrome with corpus callosum hypoplasia and white matter abnormalities First author:Argilli E Journal:The American Journal of Human Genetics DOI:10.1016/j.ajhg.2026.10.003 Reference:Argilli E., Yang C., Le C., Retallack H., Elashoff A.M., Parks K., et al. Recurrent de novo ABI2 p.Tyr491Cys variants define a neurodevelopmental syndrome with corpus callosum hypoplasia and white matter abnormalities. The American Journal of Human Genetics. (2026). https://doi.org/10.1016/j.ajhg.2026.10.003 License:This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/ Support:Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase More at basebybase.com On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics. Episode link: https://basebybase.com/episodes/abi2-tyr491cys-corpus-callosum-neurodevelopmental-syndrome QC:This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded. QC Summary:- sentences checked: 81- supported by the article: 80- flagged and reviewed by a human: 1- metadata checks passed: 4 of 4 QC result: Pass. Chapters (00:00:03) - A consistent mark on the brain(00:01:08) - Intro and fact-check note(00:01:29) - Study background and ABI2's biology(00:03:22) - Building the cohort(00:04:35) - Locating the recurrent variant(00:05:13) - Clinical features of affected individuals(00:05:49) - Brain MRI findings and the contrast cases(00:07:41) - What it all means and pathway links(00:08:25) - Limitations of the study(00:09:01) - Conclusions and outro
Penkert J et al., The American Journal of Human Genetics - Carriers of disease-causing TP53 variants range from mild to severe cancer phenotypes. Using relative fitness scores from a deep CRISPR mutagenesis screen of 9,225 TP53 mutations, this registry study of 437 individuals from 168 families shows that variants scoring 0.673 or higher go with earlier cancer and with full Li-Fraumeni syndrome. Key terms: Li-Fraumeni syndrome, TP53, deep CRISPR mutagenesis, relative fitness score, cancer surveillance. Study Highlights:A previous screen introduced 9,225 TP53 mutations into a colorectal cancer cell line and scored how well each mutant survived TP53 activators, giving a relative fitness score (RFS). The authors linked these scores to 437 individuals from 168 families in the German Cancer Predisposition Syndrome Registry. Carriers of variants with an RFS of 0.673 or higher developed cancer earlier; an RFS below 0.673 had a hazard ratio of 0.41 (95% CI 0.25 to 0.66, p 0.0002) for cancer. The association held among the 407 individuals whose variant is predicted to produce an altered protein, excluding NULL variants (hazard ratio 0.43). Families with a high score met the definition of Li-Fraumeni syndrome in 110 of 148 cases (74.3%), against 3 of 20 (15%) with a low score. Conclusion:Relative fitness scores from deep CRISPR mutagenesis separated TP53 variant carriers with earlier cancer and more severe Li-Fraumeni spectrum phenotypes, which suggests they could feed future variant classification and tailored surveillance. The finding was not validated in an independent cohort, the scores come from a single colorectal cell line, and they exist only for variants in the DNA binding domain. Article title:Deep CRISPR mutagenesis predicts cancer risk in Li-Fraumeni syndrome First author:Penkert J Journal:The American Journal of Human Genetics DOI:10.1016/j.ajhg.2026.09.016 Reference:Penkert J., Großhennig A., Dutzmann C.M., Ewert A., Zimmer R., Schoene-Bake J., et al. Deep CRISPR mutagenesis predicts cancer risk in Li-Fraumeni syndrome. The American Journal of Human Genetics. (2026). https://doi.org/10.1016/j.ajhg.2026.09.016 License:This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/ Support:Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase More at basebybase.com On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics. Episode link: https://basebybase.com/episodes/crispr-fitness-score-cancer-risk-li-fraumeni QC:This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded. QC Summary:- sentences checked: 88- supported by the article: 87- flagged and reviewed by a human: 1- metadata checks passed: 4 of 4 QC result: Pass. Chapters (00:00:03) - Introduction: TP53 Variants and Li Fraumeni Syndrome(00:01:09) - About This Podcast(00:01:31) - Study Background and Authors(00:02:00) - TP53 Gene Function and Disease Spectrum(00:02:34) - Classifying Full vs Attenuated Li Fraumeni Syndrome(00:03:09) - Measuring Variant Disruption via Deep CRISPR Mutagenesis(00:04:49) - Patient Cohort and Fitness Score Analysis(00:05:30) - Survival Differences by Score Cutoff(00:06:28) - Testing Robustness: Excluding Null Variants(00:07:03) - Family-Level Severity Predictions(00:08:15) - Study Limitations(00:08:47) - Conclusions and Future Implications(00:09:24) - Closing and Credits
Tzoumkas K et al., The American Journal of Human Genetics - COL4A3 and COL4A4 are paralogous genes that build the same collagen IV network in the kidney filter, and variant guidelines have generally treated them as interchangeable. This episode follows a population-scale study in the UK Biobank, replicated in All of Us, showing that truncating and NC1 domain missense variants carry much stronger associations with hematuria and proteinuria in COL4A4 than in COL4A3, while glycine substitutions behave alike in both genes. Key terms: COL4A3, COL4A4, Alport syndrome, hematuria, UK Biobank. Study Highlights:Using whole-genome sequencing from the UK Biobank (n ≈ 500,000) with replication in All of Us (n ≈ 414,000), the authors ran per-variant association tests, gene-based collapsing analyses and phenome-wide association studies across hematuria, proteinuria and chronic kidney disease. They identified 64 COL4A3 and 92 COL4A4 rare variants significantly associated with hematuria or proteinuria. Glycine substitutions in the collagenous domain conferred similar risks in both genes, but truncating and NC1 missense variants were strongly associated with disease only in COL4A4, with proteinuria case rates of 52.7% and 37.2% in COL4A4 compared with 17.1% and 12.1% in COL4A3. The difference persisted after excluding the British founder variant p.Ser969Ter and was independently replicated in All of Us. A genome-wide analysis found the COL4A3 and COL4A4 locus to be the dominant genetic signal for hematuria, accounted for by rare coding variants, with no evidence of independent trans-acting modifiers. Conclusion:The authors conclude that gene identity, not variant class alone, should inform risk stratification, variant interpretation and genetic counseling in collagen IV heterozygotes. The analyses were restricted to individuals of European ancestry, phenotypes came from ICD-10 codes and laboratory data that likely underestimate prevalence, the difference was not extended to severe CKD, and the mechanism behind the gene-specific effect remains speculative. Article title:Population-scale genomics reveals divergent pathogenicity of variant classes across paralogous collagen IV genes First author:Tzoumkas K Journal:The American Journal of Human Genetics DOI:10.1016/j.ajhg.2026.10.002 Reference:Tzoumkas K., Doctor G.T., Sadeghi-Alavijeh O., Gale D.P. Population-scale genomics reveals divergent pathogenicity of variant classes across paralogous collagen IV genes. The American Journal of Human Genetics. (2026). https://doi.org/10.1016/j.ajhg.2026.10.002 License:This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/ Support:Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase More at basebybase.com On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics. Episode link: https://basebybase.com/episodes/col4a3-col4a4-divergent-pathogenicity QC:This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded. QC Summary:- sentences checked: 175- supported by the article: 174- flagged and reviewed by a human: 1- metadata checks passed: 4 of 4 QC result: Pass. Chapters (00:00:03) - Introduction: Two Collagen Genes, One Question(00:00:39) - About Base by Base(00:01:00) - Type 4 Collagen Genes and Alport Syndrome(00:02:50) - Forms of Alport Syndrome and Heterozygote Risk(00:04:07) - Protein Structure and Variant Classes(00:05:03) - Testing the Paralogue Assumption at Population Scale(00:06:02) - Study Data: UK Biobank and Phenotype Definitions(00:07:16) - Three Levels of Analysis Design(00:09:05) - Single Variant Results for Hematuria and Proteinuria(00:10:29) - Gene Divergence Emerges: Truncating Variants(00:11:37) - Testing the Founder Variant's Influence(00:12:20) - NC1 Missense Variants Confirm the Pattern(00:13:03) - Formal Comparison of Effect Sizes(00:13:47) - Replication in All of Us Cohort(00:14:31) - Genome-Wide Scan Findings(00:15:17) - Interpreting the Genome-Wide Signal(00:15:53) - Clinical Implications for Genetic Counseling(00:16:34) - Why Might the Chains Differ?(00:17:14) - Study Limitations(00:17:54) - Summary and Closing Thoughts(00:19:06) - Credits and Sign-off
Klaver M et al., The EMBO Journal - In 1961, Hayflick and Moorhead showed that normal human fibroblasts divide only a finite number of times. This episode follows a review of the six decades since, as senescence moved from a cell-culture limit to a tumor-suppressive stress response, a tissue-remodeling program, a contributor to aging and disease, and a target for therapy. Key terms: cellular senescence, SASP, senolytics, senomorphics, aging. Study Highlights:This review traces cellular senescence from the Hayflick limit of 1961 through telomere shortening, biomarkers and oncogene-induced senescence. The senescence-associated secretory phenotype revealed that senescent cells actively communicate with their tissues, and later work showed there is no single universal SASP. Genetic ablation in mice showed that senescent cells can contribute causally to age-related decline, while other studies showed roles in wound healing, development and tissue repair, and one p16-lineage study reported detrimental effects on the liver. Senolytics such as dasatinib plus quercetin and senomorphics followed, but UBX0101 failed to show significant benefit in Phase 2 and UBX1325 missed its Phase 2b primary endpoint. The authors identify the lack of validated biomarkers of target engagement as the major bottleneck in clinical senotherapy. Conclusion:The authors conclude that senescence is neither inherently beneficial nor inherently detrimental, and that its consequences depend on context, which senescent cells are involved, and how long they persist. This is a narrative review, not a new experiment, and much of the causal evidence comes from mouse models, with human trials so far early, limited by size or design, or unsuccessful. Article title:Cellular senescence: six decades of discovery and reinvention First author:Klaver M Journal:The EMBO Journal DOI:10.1038/s44318-026-00922-w Reference:Klaver M., Steeneken L.S., Veeningen N., Altulea A., Demaria M. Cellular senescence: six decades of discovery and reinvention. The EMBO Journal, 45, 7307-7325. (2026). https://doi.org/10.1038/s44318-026-00922-w License:This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/ Support:Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase More at basebybase.com On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics. Episode link: https://basebybase.com/episodes/cellular-senescence-six-decades-review QC:This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded. QC Summary:- sentences checked: 183- supported by the article: 182- flagged and reviewed by a human: 1- metadata checks passed: 4 of 4 QC result: Pass. Chapters (00:00:03) - Introduction: The Hayflick Discovery(00:00:44) - About This Episode and Paper(00:02:30) - Telomere Shortening as a Mechanism(00:03:11) - Finding Markers for Senescence in Tissue(00:03:58) - Oncogene-Induced Senescence and Tumor Suppression(00:04:41) - Multiplying Triggers of Senescence(00:05:29) - Discovery of the SASP Secretory Phenotype(00:06:18) - Complexity and Diversity of SASP Programs(00:07:08) - Testing Causality: Senescent Cell Clearance Models(00:08:25) - Beneficial Roles in Healing and Repair(00:09:00) - Developmental Senescence Discovery(00:10:12) - Senescence and the Aging Hallmarks Framework(00:10:51) - The Persistence Paradox and Disease Links(00:11:37) - Immune Clearance of Senescent Cells(00:12:37) - Immune Evasion and Immunosenescence(00:13:08) - Senolytics: Targeting Senescent Cells(00:13:59) - Senomorphics: Suppressing the SASP(00:14:47) - Early Human Clinical Trials(00:15:32) - Clinical Setbacks and Failures(00:16:16) - The Biomarker Bottleneck(00:17:04) - Toward Precision Senescence Targeting(00:17:51) - Conclusion: Context-Dependent Senescence(00:18:28) - Future Directions and Closing Thoughts
loading
Comments